Physiology
The standard equation for arterial blood oxygen content shows that about 99% of the arterial oxygen is normally in the form of hemoglobin-bound O 2 :
CaO 2 = 1.38 (SaO 2 /100)(Hb) + 0.003 PaO 2 [1] CaO 2 is the arterial oxygen content in ml per 100 ml of blood (also called vols%); SaO 2 is the arterial hemoglobin saturation in percent; Hb is the total hemoglobin concentration in grams per 100 ml; and PaO 2 is the arterial blood oxygen tension in mmHg.
The normal relationship between SaO 2 and PaO 2 is the familiar oxyhemoglobin dissociation curve. Three convenient reference points on this curve are: PaO 2 = 27, SaO 2 thus becomes almost independent of PaO 2 . It is important to remember this fact during SaO 2 monitoring in the operating room, where elevated FIO 2 values tend to yield PaO 2 values well above 90 mmHg most of the time. Knowledge of the relationship of hemoglobin saturation and PaO 2 allows us to predict the physiologic limitations of pulse oximetry. For example, the pulse oximeter will give no indication of early trends in PaO 2 during anesthesia at elevated inspired oxygen fraction (FIO 2 ) until PaO 2 values less than 90 mmHg are reached. In an animal experiment, endobronchial intubations at FIO 2 values greater than 30% were usually undetected by the pulse oximeter (1) .
Technology
Oximetry determines the blood concentrations of various hemoglobin species by measuring the absorbance of light at multiple wavelengths. The number of wavelengths used must be equal to or greater than the number of hemoglobin species present. A laboratory CO-oximeter, which uses four or more wavelengths, can measure the concentrations of reduced hemoglobin, O 2 Hb, MetHb, and COHb. If all four of these hemoglobins are present in significant concentrations, then an oximeter must utilize at least four wavelengths to determine the concentration of any of the four species.
The pulse oximeter is a two-wavelength oximeter that functions in vivo. Conventional pulse oximetry determines the fluctuating or "AC" component of the light absorbance signal. At each of its two wavelengths the oximeter divides this AC signal by the corresponding "DC" component to obtain a "pulse-added absorbance". It then calculates the ratio of the pulse-added absorbances for the two wavelengths, and this ratio R is related to SaO 2 by a built-in calibration algorithm. 
Sources of error
Dyshemoglobins: As noted above, the pulse oximeter employs two wavelengths and can thus distinguish only two hemoglobin species: Hb and O 2 Hb. If either COHb or MetHb is present, the pulse oximeter effectively has fewer equations than unknowns, and it is unable to find any of the hemoglobin concentrations. It is not clear a priori how the pulse oximeter will behave in the presence of various dyshemoglobins.
Two animal experiments have characterized pulse oximeter behavior during dyshemoglobinemias. In one study, dogs were exposed to carbon monoxide over a 3-4 hour period (2) . At lethal carboxyhemoglobin levels of 70%, the SpO 2 values were roughly 90% while the actual SaO 2 was 30%. The pulse oximeter thus "sees" COHb as if it were composed mostly of O 2 Hb. In a similar experiment, high MetHb levels were achieved in dogs using benzocaine (3) . As hypoxia was worsened by lowering FIO 2 , SpO 2 failed to measure either functional or fractional saturation. Clinical case reports have supported the results of these studies.
Intravenous dyes: As abnormal hemoglobin species can affect the accuracy of pulse oximetry, so can intravenous dyes injected during surgery or critical care. Two studies found that intravenous methylene blue causes large decreases in displayed SpO 2 without changes in actual saturation, and that indocyanine green causes smaller false decreases in SpO 2 (4, 5) . Reductions in peripheral pulsation; ambient light: Several studies have examined the effects of low perfusion upon SpO 2 (6, 7) . In a clinical study in the critically ill under a wide range of hemodynamic conditions, extremes in systemic vascular resistance were associated with loss of pulse oximeter signal or decreased accuracy. During reduced pulse amplitude, pulse oximeters may become sensitive to external light sources, such as fluorescent room lights (8) . Most pulse oximeters actually measure and correct for ambient light intensity many times per second.
Motion artifact: Patient motion, which causes a large fluctuating absorbance signal, is a challenging artifact. Motion artifact rarely causes difficulty in the operating room, but in the recovery room and intensive care unit it can make the pulse oximeter useless. Design engineers have tried several approaches to this problem, beginning with increasing the signal averaging time. Most pulse oximeters now allow the user to select one of several time averaging modes. Masimo, Inc. has developed a new approach to the analysis of the oximeter light absorbance signals, using adaptive digital filtering. This has led to improved performance during motion artifact, both in laboratory studies (9) and in the neonatal intensive care unit (10) . This new technology has spurred other manufacturers (Nellcor, Philips, Datex-Ohmeda, Novametrix) to redesign their own signal analysis methods, so that the new generation of pulse oximeters will have improved reliability and accuracy during both motion and low perfusion. These improvements in reliability and accuracy will improve the quality of care while reducing the need for frequent arterial blood-gas analysis (11) .
Venous pulsations: Conventional pulse oximeter design is based upon the assumption that the pulsatile component of the light absorbance is due entirely to arterial blood. However, the light absorbance of venous blood can also pulsate, and this may affect SpO 2 values under some conditions (12) . SpO 2 may read falsely low values in circumstances leading to venous congestion, particularly in sensors located on the head or face. The Masimo algorithm assumes that both venous and arterial absorbances are pulsatile, and it measures their contributions independently.
Penumbra effect: When a pulse oximeter sensor is not properly positioned on the finger or earlobe, light traveling from the source to the detector may pass through tissue at a grazing incidence. This "penumbra effect" reduces the signal-to-noise ratio, and may result in SpO 2 values in the low 90's in a normoxemic subject. More concerning, a volunteer study has shown that in hypoxemic subjects, this effect can cause SpO 2 to either overestimate or underestimate actual SaO 2 values, depending upon the specific instrument (13) . Thus a pulse oximeter with a malpositioned sensor may tell the clinician that a patient is only mildly hypoxemic when in fact he/she is profoundly so.
OXYGEN IN ARTERIAL BLOOD: 2. CONTINUOUS INTRAARTERIAL PO 2
There have been numerous attempts to monitor intraarterial PO 2 using miniaturized probes passed through arterial cannulas. The first practical approach to this problem employed Clark electrodes, the same oxygen electrode used in the conventional laboratory blood-gas analyzer. Although miniaturized Clark electrodes have been used in clinical studies, the technique has never achieved popularity owing to problems with calibration drift and thrombogenicity (14) . More recently, the principle of fluorescence quenching has been used to develop fiberoptic "optodes" which can continuously monitor pH, PaCO 2 and PaO 2 through a 20 gauge arterial cannula.
Technical considerations. Fluorescence quenching is a result of the ability of oxygen or other molecules to absorb energy from the excited states of a fluorescent dye, thus preventing this energy from being radiated as light. Lubbers developed the first fluorescence quenching "optode" that simultaneously measured PO 2 and PCO 2 in gases or liquids (15) . In the 1980's optodes were successfully miniaturized, and a number of intraarterial studies were reported in both animal and humans (16, 17) .
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Clinical studies. Several clinical studies have demonstrated the utility of intraarterial optodes in the operating room (18) . The error of optode PO 2 values is actually lowest at low oxygen tensions, a useful characteristic of these sensors. The accuracy of the optode can be within the clinically acceptable range, especially when 18 gauge radial artery cannulas are used. Accuracy seems to be lower when 20 gauge cannulas are used. The optode can display blood-gas data continuously at the patient's bedside, with a time response measured in seconds. However, the high costs of the disposable sensors (near $300 each) and their inconsistent reliability have caused intraarterial optodes to nearly disappear from the market. Optodes have other promising applications in tissues and organs that may be realized in the future. They are being marketed today for measuring the viability of tissue grafts and surgical flaps.
OXYGEN IN TISSUE: TRANSCUTANEOUS OXYGEN
Physiology. The transcutaneous oxygen sensor is a Clark electrode that measures oxygen diffusing to the surface of the skin from dermal capillaries. This electrode (the same one that is in the blood-gas analyzer) measures oxygen tension, which is an important distinction from the pulse oximeter, which estimates hemoglobin saturation. The sensor must be heated to at least 43-45°C to facilitate oxygen diffusion through the stratum corneum. Surface heating also produces a local hyperemia of the dermal capillary bed, which tends to "arterialize" the blood and cause a rightward shift in the oxyhemoglobin dissociation curve. These effects, which tend to increase transcutaneous oxygen tension (PtcO 2 ) are counterbalanced by effects that decrease it, namely diffusion gradients and metabolic O 2 consumption by the skin. In neonates the competing effects nearly balance, and PtcO 2 is roughly equal to PaO 2 . In adults, the stratum corneum is thicker and PtcO 2 is therefore lower than PaO 2 . The transcutaneous index, PtcO 2 /PaO 2 , has average values of 1.0 in neonates, 0.9 in pediatric patients, 0.8 in adults, and 0.6 to 0.7 in the elderly.
The most serious problem with the interpretation of PtcO 2 is its dependence upon both cardiac output and skin perfusion. Both human and animal studies have shown that the transcutaneous index falls when the cardiac index decreases below its normal range (19, 20) . Studies of animals during hypovolemic shock have shown that PtcO 2 closely follows changes in oxygen delivery, i.e. the product of cardiac output and arterial oxygen content (19) . In other words, PtcO 2 monitors oxygen delivery to the tissues rather than oxygen content of arterial blood.
Technical problems. There are several practical problems associated with the use of PtcO 2 sensors. The electrode must be calibrated before each application to the skin. After application, the sensor requires a 10 to 15 minute warm-up period. In pediatric patients this warm-up period is closer to 5 minutes. The sensor's membrane and electrolyte must be replaced periodically. The heated PtcO 2 electrode can cause small (0.5 cm) skin burns, particularly at temperatures of 44°C or greater. Lower probe temperatures (43 or 43.5°C) should be used on premature infants and neonates, and the probe site should be changed every 2 to 3 hours. In adults with a sensor temperature of 44°C, we have used the same location for 6 to 8 hours with no incidence of burns.
Conclusions: PtcO and SpO 2 . PtcO 2 provides continuous, noninvasive monitoring of oxygen delivery to tissues. By contrast, SpO 2 (pulse oximetry) monitors arterial hemoglobin saturation, which by itself does not determine O 2 delivery. The dependence of PtcO 2 upon both skin perfusion and PaO 2 makes it more difficult to interpret changing values. If PtcO 2 is normal or high, we know that the tissues are well oxygenated. When PtcO 2 decreases, it is a sign that either PaO 2 or blood flow is decreasing -it is up to us to determine the cause.
In the near future, we expect to see new developments in organ-specific oxygen monitors, permitting us to measure the status of the brain, heart, kidneys, and other vital organs or tissues.
OXYGEN IN VENOUS BLOOD: PULMONARY ARTERY OXIMETRY
Physiology of mixed venous saturation. Blood oxygen saturation SO 2 is related to blood oxygen content C(O 2 ) by the equation:
where Hb is hemoglobin in gm/dl, SO 2 is %-saturation, and PO 2 is oxygen tension in mmHg. Inserting typical arterial values (Hb = 15, SaO 2 = 98%, PaO 2 = 95 mmHg), we find CaO 2 = 20.6 cc/dl. The corresponding venous oxygen content value (with SvO 2 = 75%, PvO 2 = 40 mmHg) is CvO 2 = 15.6 cc/dl.
The total oxygen transport to the tissues, or O 2 delivery, is given by: In the last step, we have neglected the small contribution of dissolved oxygen content (0.003 • PO 2 ) and replaced C(O 2 ) with 1.38•Hb•SO 2 . In a "normal" patient having the values given above, we obtain: That is, VO 2 can increase at least nine-fold. Note that SvO 2 has fallen to 31% in this highly stressed subject, representing maximum theoretical oxygen uptake by tissue.
When O 2 consumption falls behind O 2 demand, lactic acidosis will develop, eventually leading to death if the problem is not corrected. When this begins to occur in disease (e.g., anemia), the patient will attempt to compensate and maintain O 2 consumption by using the same two mechanisms shown above: increasing C.O. and/or decreasing SvO 2 . In the case of anemia, this compensation can maintain normal O 2 consumption even at hemoglobin values below 3 gm/dl! Thus a decrease in SvO 2 indicates that a patient is using "oxygen reserves" to compensate for a supply/demand imbalance. Decreasing oxygen supply can result from low cardiac output, low Hb, abnormal Hb (e.g., carboxyhemoglobin), or low PaO 2 . Increasing oxygen demand can result from fever, malignant hyperthermia, thyrotoxicosis, or shivering.
All Technical considerations. Pulmonary artery SvO 2 catheters use the technology of reflectance spectrophotometry; that is, they measure the color of the blood in a manner similar to pulse oximetry. Modern SvO 2 catheters use fiberoptic bundles to transmit and receive light from the catheter tip. Light-emitting diodes provide monochromatic light sources at two or three known wavelengths. A theoretical advantage of the three-wavelength system is that its measurements should not depend upon the hemoglobin value (21) . One technical problem in SvO 2 catheters is the so-called "wall artifact", whereby reflection from a vessel wall can produce a signal that is interpreted as an SvO 2 of 85-90%. This problem has been reduced by the addition of digital filtering to the processor, which edits out sudden stepwise increases in SvO 2 . However, a persistently high SvO 2 value should alert the user that the PA catheter may be in the wedged condition and hence is producing wall artifact.
Applications and limitations. Let us consider some clinical examples of continuous SvO 2 monitoring in the operating room and ICU, bearing in mind Equation 4. Whenever SvO 2 changes, we should ask ourselves which terms in Eqn. 4 are responsible. In the operating room, the terms most likely to change significantly are C.O. and Hb. During general anesthesia, SaO 2 and VO 2 are usually constant, with the exception that VO 2 will fall during hypothermia. In the ICU, however, any of the four variables (C.O., Hb, VO 2 , SaO 2 ) can change. Patients in respiratory failure will have varying degrees of arterial desaturation. Note that SvO 2 is directly coupled to SaO 2 ; that is, if SaO 2 falls by 20% and nothing else changes, SvO 2 will fall by 20%. ICU patients also have frequent changes in VO 2 , which may be increased by agitation, shivering, coughing, fever, pain, seizures, defecation, or lunch, to name just a few possibilities.
Continuous SvO 2 is a valuable adjunct in the management of ventilator-dependent patients. As we slowly increase PEEP to improve oxygenation in the ARDS patient, SaO 2 will generally increase, but eventually C.O. will decrease as venous return is compromised. At this point, oxygen delivery to tissue may begin decreasing even though SaO 2 is still increasing. SvO 2 is a reflection of oxygen delivery in this case, and can thus provide a means of "optimizing" PEEP without serial blood gases and cardiac output measurements.
An important limitation of pulmonary oximetry is measurement error resulting from unknown light absorbers (or reflectors) in the blood. Just as pulse oximeters are confused by the presence of intravenous dyes or dyshemoglobins, we have shown in animals that even a three-wavelength SvO 2
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In summary, continuous SvO 2 is another valuable O 2 -transport monitor for the operating room and the ICU. To benefit most from this device, we must thoroughly understand the physiology of SvO 2 and how it relates to other cardiopulmonary variables.
The monitoring of patient oxygenation has progressed in the past 20 years from simple measurement of FiO 2 to routine monitoring of oxygen in both arterial and venous blood.
Hopefully, the next 20 years will witness the development of monitors that determine the oxygen status of each of the vital organs, allowing us to treat oxygen delivery problems when and where they occur.
